Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Stoke Therapeutics Inc buy BTIG Research

Start price
€19.00
05.11.25 / 50%
Target price
€33.93
05.11.26
Performance (%)
42.11%
Price
€27.00
27.11.25
Summary
This prediction is currently active. The BUY prediction by BTIG_Research for Stoke Therapeutics Inc has seen massive gains of 42.11%. This prediction currently runs until 05.11.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this prediction
Performance without dividends (%)
Name 1w
Stoke Therapeutics Inc 11.570%
iShares Core DAX® 2.705%
iShares Nasdaq 100 4.127%
iShares Nikkei 225® 1.944%
iShares S&P 500 2.919%

Comments by BTIG_Research for this prediction

In the thread Stoke Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 42.11%
Target price 33.934
Change
Ends at 05.11.26

Stoke Therapeutics (NASDAQ:STOK) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $39.00 price target on the stock.
Ratings data for STOK provided by MarketBeat

Stopped prediction by BTIG_Research for Stoke Therapeutics Inc

buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€26.60
14.10.25
€33.70
14.10.26
1.50%
27.11.25

buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€15.60
18.08.25
€23.93
18.08.26
73.08%
27.11.25